Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC16A3 | O15427 | 2/20 | 0.48 |
| ▸ | SLC16A1 | P53985 | 2/20 | 0.48 |
| ▸ | NR1H2 | P55055 | 5/20 | 0.41 |
| ▸ | NR1H3 | Q13133 | 5/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | AR | P10275 | 1/20 | 0.36 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.36 |
| ▸ | EGFR | P00533 | 1/20 | 0.35 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11939407 | 0.81 | SLC16A3 (0.50) | SLC16A3SLC16A1NR1H2NR1H3ALDH1A1 | |
| SCHEMBL12304301 | 0.80 | SLC16A3 (0.44) | SLC16A3SLC16A1ALDH1A1L3MBTL1 | |
| SCHEMBL2950543 | 0.79 | CRHR1 (0.42) | NR1H2NR1H3ALDH1A1KDM4EPOLB | |
| SCHEMBL19496111 | 0.78 | SLC16A3 (0.48) | SLC16A3SLC16A1NR1H2NR1H3ALDH1A1 | |
| SCHEMBL1573445 | 0.78 | CNR2 (0.47) | SLC16A3SLC16A1ALDH1A1GAANR1I2 | |
| SCHEMBL2954673 | 0.78 | NR1H2 (0.43) | NR1H2NR1H3ALDH1A1KDM4EPOLB | |
| SCHEMBL16248320 | 0.78 | SLC16A3 (0.47) | SLC16A3SLC16A1NR1H2NR1H3ALDH1A1 | |
| SCHEMBL1577124 | 0.78 | SLC16A3 (0.52) | SLC16A3SLC16A1ALDH1A1L3MBTL1MEN1 | |
| SCHEMBL23350318 | 0.77 | SLC16A3 (0.47) | SLC16A3SLC16A1NR1H2NR1H3ALDH1A1 | |
| SCHEMBL23350317 | 0.77 | SLC16A3 (0.50) | SLC16A3SLC16A1NR1H2NR1H3ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7759504-B2 | Diimmonium compound having perchlorate ion or hexafluorophosphate ion as counter ion with sufficient heat resistance and solubility; photopolymerization initiator and electrophotographic photoreceptor | FUJIFILM CORPORATION (JP) | 2010-07-20 | — | — | US | disclosed |
| US-20080255387-A1 | TRIARYLAMINE DERIVATIVE | FUJIFILM CORPORATION (JP) | 2008-10-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080255387-A1 | TRIARYLAMINE DERIVATIVE | METTL14, MYH14, TOMM22 | SLC16A3 3418/4885SLC16A1 3292/4885NR1H2 911/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.